Differential LRRK2 Signalling and Gene Expression in WT-LRRK2 and G2019S-LRRK2 Mouse Microglia Treated with Zymosan and MLi2

Mutations in the leucine-rich repeat kinase 2 (<i>LRRK2</i>) gene cause autosomal dominant Parkinson’s disease (PD), with the most common causative mutation being the <i>LRRK2</i> p.G2019S within the kinase domain. LRRK2 protein is highly expressed in the human brain and also in the periphery, and h...

Полное описание

Библиографические подробности

Главные авторы:	Iqra Nazish, Adamantios Mamais, Anna Mallach, Conceicao Bettencourt, Alice Kaganovich, Thomas Warner, John Hardy, Patrick A. Lewis, Jennifer Pocock, Mark R. Cookson, Rina Bandopadhyay
Формат:	Artigo
Язык:	Inglês
Опубликовано:	MDPI AG 2023-12-01
Серии:	Cells
Предметы:	<i>LRRK2</i> TLR2 LRRK2 p.G2019S knock-in zymosan MLi.2 RNA-Seq
Online-ссылка:	https://www.mdpi.com/2073-4409/13/1/53
Метки:	Добавить метку Нет меток, Требуется 1-ая метка записи!